Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

Presentation TCT 2023

TCT 462: Immediate Versus Staged Complete Revascularisation Angina-Related Quality of Life in patients Presenting With Acute Coronary Syndrome and Multivessel Coronary Disease : Results From the Prospective, Open-Label, Non-Inferiority, Randomised…

Presenter: Paul Cummins

October 26, 2023

Presentation TCT 2023

TCT 225: Ten-year Clinical Outcomes of Vasospastic Angina documented by Intracoronary Drug Provocation Tests in Korean Population

Presenter: Seung-Woon Rha

October 25, 2023

Presentation TCT 2023

Coronary Sinus Reducer Improves Angina and Coronary Flow Reserve in Patients With Coronary Microvascular Dysfunction

Presenter: David Tryon

October 25, 2023

Presentation TCT 2023

TCT 812: Stentless strategy for a patient with unstable angina involving the left main trunk scheduled for invasive treatment for hepatocellular carcinoma

Presenter: Kensho Matsuda

October 24, 2023

Presentation TCT 2023

Discussion & Closing Comments

Presenter: Timothy Henry

October 24, 2023

Presentation TCT 2023

The Future of Clinical Data for The Reducer

Presenter: Megha Prasad

October 24, 2023

Presentation TCT 2023

The Coronary Sinus Reducer

Presenter: Stefan Verheye

October 24, 2023

Presentation TCT 2023

Patients – Where are They?

Presenter: Timothy Henry

October 24, 2023

Presentation TCT 2023

Angina – The Scope of the Challenge

Presenter: Allen Jeremias

October 24, 2023

Presentation TCT 2023

TCT 430: Prognostic Value of Combined Coronary CT Angiography-derived Fractional Flow Reserve and Quantitative Plaque Analysis in Patients With Stable Angina

Presenter: Kristian Taekker Madsen

October 24, 2023

Presentation TCT 2023

TCT 428: Coronary CT Angiography-derived Fractional Flow Reserve and Risk of Recurrent Angina in Stable Coronary Artery Disease: A 3-year Follow-up Study

Presenter: Kristian Taekker Madsen

October 24, 2023

Presentation TCT 2023

TCT 744: Microvascular Dysfunction Is Associated With Reduced Nailfold Capillary Density in Patients with Angina With No Obstructive Coronary Artery Disease

Presenter: ATHANASIOS SAKALIDIS

October 24, 2023

Presentation TCT 2023

Causes for Angina Without Obstructive Coronary Disease

Presenter: Dany Jacob

October 23, 2023

Presentation CTO 2023

Effect of Percutaneous Coronary Intervention on Reduce Metalloproteinase 9 (MMP-9), Soluble Suppression of Tumorigenicity 2 (sST2), N Terminal Pro B-Type Natriuretic Peptides (NT Pro BNP) and Anginal Component in Quality of Life of Chronic Total…

Presenter: I Made Junior Rina Artha

February 23, 2023

Advertisement

TCT 462: Immediate Versus Staged Complete Revascularisation Angina-Related Quality of Life in patients Presenting With Acute Coronary Syndrome and Multivessel Coronary Disease : Results From the Prospective, Open-Label, Non-Inferiority, Randomised…

TCT 225: Ten-year Clinical Outcomes of Vasospastic Angina documented by Intracoronary Drug Provocation Tests in Korean Population

Coronary Sinus Reducer Improves Angina and Coronary Flow Reserve in Patients With Coronary Microvascular Dysfunction

TCT 812: Stentless strategy for a patient with unstable angina involving the left main trunk scheduled for invasive treatment for hepatocellular carcinoma

Discussion & Closing Comments

The Future of Clinical Data for The Reducer

The Coronary Sinus Reducer

Patients – Where are They?

Angina – The Scope of the Challenge

TCT 430: Prognostic Value of Combined Coronary CT Angiography-derived Fractional Flow Reserve and Quantitative Plaque Analysis in Patients With Stable Angina

TCT 428: Coronary CT Angiography-derived Fractional Flow Reserve and Risk of Recurrent Angina in Stable Coronary Artery Disease: A 3-year Follow-up Study

TCT 744: Microvascular Dysfunction Is Associated With Reduced Nailfold Capillary Density in Patients with Angina With No Obstructive Coronary Artery Disease

Causes for Angina Without Obstructive Coronary Disease

Effect of Percutaneous Coronary Intervention on Reduce Metalloproteinase 9 (MMP-9), Soluble Suppression of Tumorigenicity 2 (sST2), N Terminal Pro B-Type Natriuretic Peptides (NT Pro BNP) and Anginal Component in Quality of Life of Chronic Total…

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content